# Can Amygdala-Derived-EEG-fMRI-Pattern (EFP) Neurofeedback Treat Sleep Disturbances in PTSD?

**Authors:** Aron Tendler, Yaki Stern, Tal Harmelech

PMC · DOI: 10.3390/brainsci15030297 · Brain Sciences · 2025-03-12

## TL;DR

A new neurofeedback treatment targeting the amygdala may help improve sleep in people with PTSD.

## Contribution

This study explores a novel amygdala-targeted neurofeedback approach for PTSD-related sleep issues.

## Key findings

- 63.79% of participants showed meaningful sleep improvement at 3-month follow-up.
- Sleep improvement correlated with overall PTSD symptom reduction (r = 0.484).
- Sleep responders showed increased cognitive reappraisal (mean change +2.57).

## Abstract

Background: Sleep disturbances are a core feature of post-traumatic stress disorder (PTSD), affecting up to 90% of patients and often persisting after standard PTSD treatment. As all the current interventions have limitations, amygdala-targeted neuromodulation may offer a novel treatment pathway. Methods: Secondary analysis of a prospective, single-arm trial (n = 58) was carried out evaluating Prism™ amygdala-derived-EEG-fMRI-Pattern neurofeedback (Amyg-EFP-NF). Sleep outcomes were assessed using the Clinician-Administered PTSD Scale (CAPS-5) sleep item, PTSD Checklist (PCL-5) sleep item, and Patient Health Questionnaire (PHQ-9) sleep items at baseline, post-treatment, and 3-month follow-up. Treatment consisted of 15 sessions over 8 weeks. Results: At 3-months’ follow-up, 63.79% of participants demonstrated clinically meaningful reduction in sleep disturbances (≥1 point reduction in CAPS-5 Item 20). Sleep improvement showed a moderate correlation with overall PTSD symptom reduction (r = 0.484, p < 0.001) and a balanced improvement pattern (−15.1% early, −9.1% late). Sleep responders sustained improvement across multiple measures and showed significant increases in cognitive reappraisal (mean change: +2.57 ± 1.0, p = 0.006), while non-responders showed initial but un-sustained improvement in trauma-related dreams. Conclusions: Amyg-EFP-NF shows preliminary promise for treating PTSD-related sleep disturbances. Our exploratory analyses suggest distinct temporal patterns of sleep improvement and potential associations with enhanced cognitive reappraisal capacity that warrant rigorous investigation in future randomized controlled trials.

## Linked entities

- **Diseases:** post-traumatic stress disorder (MONDO:0005146), PTSD (MONDO:0005146)

## Full-text entities

- **Diseases:** PTSD (MESH:D013313), Sleep Disturbances (MESH:D012893), trauma (MESH:D014947)
- **Species:** Homo sapiens (human, species) [taxon 9606]

## Full text

_Full body text omitted from this summary view._ Fetch the complete paper as Markdown: https://tomesphere.com/paper/PMC11940793/full.md

## Figures

4 figures with captions in the complete paper: https://tomesphere.com/paper/PMC11940793/full.md

## References

26 references — full list in the complete paper: https://tomesphere.com/paper/PMC11940793/full.md

---
Source: https://tomesphere.com/paper/PMC11940793